)
Rein Therapeutics (RNTX) investor relations material
Rein Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for July 20, 2026, to be held online at 9:00 AM ET.
Proxy materials and annual report are available online for review and voting.
Shareholders are encouraged to vote electronically and can opt for electronic delivery of future materials.
Voting matters and shareholder proposals
Election of two Class III directors: Reinhard J. Ambros, Ph.D., and Josef H. von Rickenbach.
Proposal to increase authorized shares of common stock.
Ratification of CBIZ CPAs P.C. as independent registered public accounting firm.
Advisory vote to approve named executive officer compensation.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and proposals listed.
- Virtual meeting to vote on directors, share increase, auditor, and executive pay; board supports all.RNTX
Proxy filing8 Jun 2026 - Board recommends voting for all proposals, including director elections and share increase.RNTX
Proxy filing28 May 2026 - Q1 2026 net loss was $5.8M; cash and new equity expected to fund operations into 2028.RNTX
Q1 202615 May 2026 - Biopharma seeks $48M via Nasdaq IPO to advance IPF drug, repay debt, and fund operations.RNTX
Registration filing29 Apr 2026 - LTI-03 advances as a promising, safe IPF therapy with dual antifibrotic and regenerative action.RNTX
Corporate presentation22 Apr 2026 - LTI-03 shows strong early safety and efficacy signals for IPF, targeting a major unmet market.RNTX
Corporate presentation22 Apr 2026 - Net loss was $49.9M in 2025; LTI-03 Phase 2 trial ongoing, but cash only funds operations into Q2 2026.RNTX
Q4 202526 Mar 2026 - LTI-03 demonstrates strong anti-fibrotic and regenerative potential for IPF with favorable safety.RNTX
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - LTI-03 reduced key fibrosis biomarkers and was well tolerated in IPF, supporting phase II trials.RNTX
Study Result14 Jan 2026
Next Rein Therapeutics earnings date
Next Rein Therapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage